Ban Sop Ruak

Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource(SM) Laboratory

Retrieved on: 
Wednesday, May 31, 2023
LEAP, QC, Portable, CMC, ATUM, CDMO, Ban Sop Ruak, CGMP, Quality control, Entrepreneurship, CRL, IND, NYSE, Fine chemical

OKLAHOMA CITY, May 31, 2023 /PRNewswire/ -- Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO), and Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement to implement RightSourceSM at Wheeler Bio's current good manufacturing practice (cGMP) biologics manufacturing facility in Oklahoma City, OK. Deployed on-site at a client's facility, RightSourceSM is a flexible biologics testing lab operated and managed by Charles River, making fast, reliable quality control (QC) more accessible to a broader reach of companies like Wheeler Bio.

Key Points: 
  • OKLAHOMA CITY, May 31, 2023 /PRNewswire/ -- Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO), and Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement to implement RightSourceSM at Wheeler Bio's current good manufacturing practice (cGMP) biologics manufacturing facility in Oklahoma City, OK.
  • Deployed on-site at a client's facility, RightSourceSM is a flexible biologics testing lab operated and managed by Charles River, making fast, reliable quality control (QC) more accessible to a broader reach of companies like Wheeler Bio.
  • Wheeler Bio and Charles River will work in close collaboration to set up a cGMP testing lab at Wheeler Bio's ultra-modern Oklahoma City facility .
  • The RightSourceSM Laboratory at Wheeler Bio will be operational in Q3 2023 and is anticipated to start in-process and release testing by Q4 2023.

Novotech Receives "Best Biologics CRO Award 2022" at Korea Bioprocessing Excellence Awards 2022

Retrieved on: 
Tuesday, June 28, 2022
Ban Sop Ruak, Cell, CRO, Asia-Pacific, Clinical trial, Technology, Solution, Drug development, Acceleration, Lists of people executed in the United States, Fine chemical, Pharmaceutical industry

Novotech Country Managing Director Sanghee Kim said the Korea team was extremely pleased to receive this award in recognition of the clinical excellence provided to clients in the biologics sector.

Key Points: 
  • Novotech Country Managing Director Sanghee Kim said the Korea team was extremely pleased to receive this award in recognition of the clinical excellence provided to clients in the biologics sector.
  • Novotech now has a workforce of ~2,500 clinical trial professionals across Australia, New Zealand, South Korea, Greater China, Southeast Asia, India, South Africa and the US.
  • Ltd. ("Novotech") is the leading Asia-Pacific and US biotech specialist CRO.
  • Novotech has integrated labs and phase I facilities and provides drug development consulting and clinical development services across all phases.

Novotech's APAC and USA Leadership Teams at BIO 2022

Retrieved on: 
Tuesday, June 14, 2022
Acceleration, CA, OF, BIO, Workforce, Solution, ASIA, Technology, Compliance, SAN, Clinical trial, Drug development, Ethernet Global Data Protocol, Asia-Pacific, Lists of people executed in the United States, CRO, Ban Sop Ruak, Fine chemical, Pharmaceutical industry

#4907

Key Points: 
  • #4907
    Book a meeting with one of the Novotech experts at BIO here.
  • Novotech now has a workforce of ~2,500 clinical trial professionals across Australia, South Korea, Greater China, Southeast Asia, India, South Africa and the US.
  • The APAC region was the largest contributor, with more than 50% of the trials followed by the US (29%) and the EU5 (17%).
  • It has been instrumental in the success of approximately 3,700 clinical trials across a broad range of therapeutic areas.